Shift Labs Partners with Option Care to Provide Innovative, Patient-Centered IV Infusion Care in Home and Alternate Treatment Sites
SEATTLE (PRWEB) July 30, 2018 -- Shift Labs, a Seattle-based company that designs and manufactures innovative, high-quality infusion technologies, has partnered with Option Care Enterprises, Inc., a leading provider of home and alternate site infusion services, to introduce the DripAssist Infusion Rate Monitor for home infusion care. Shift Labs’ award-winning DripAssist device is a lightweight tool optimized for the needs of home care patients that provides precision real-time monitoring for any intravenous (IV) treatment.
“Patients and providers in the home have different needs than we see with hospital care, and too few companies are rising up to meet the challenge of simplifying home care and making it more comfortable,” says Beth Kolko, CEO of Shift Labs. “DripAssist gives nurses confidence and control over infusions, while freeing patients from the burden of having costly and fragile hospital equipment in their living rooms.”
DripAssist is the first product to introduce simpler infusion hardware to the rapidly expanding home and alternate site care sectors. The handheld device delivers unprecedented portability, efficiency, and ease of use to meet the unique challenges of providing and coordinating care in these settings.
“Technology-enabled nurses can even more closely monitor patients, which may lead to improved outcomes and patient experience,” says Joan Couden, VP of Nursing at Option Care. “Bringing on innovations like DripAssist allows us to leverage our extensive nursing expertise and give our patients peace of mind that they’re getting the best possible care.”
Following a comprehensive 16-city pilot, Option Care has launched DripAssist nationally for use with nurse monitored IV treatments including monoclonal antibody therapies, enzyme replacement, IVIg and hydration. These treatments, along with many other medications, biologics, and fluids, can be administered safely by a nurse using DripAssist in lieu of a traditional infusion pump.
The DripAssist platform provides unparalleled efficiencies to provider organizations; in addition to saving up to 90% per year in recurring infusion equipment costs, providers can switch to a per-nurse solution that no longer requires managing infusion pumps in every patient’s home.
As the global population ages, more solutions are needed to make alternate site care convenient and cost-effective. Option Care has established itself as a leading provider of infusion services nationally, and their introduction of DripAssist brings new innovation into the home. “At Shift Labs we’ve taken on the challenge of providing transformative solutions for high quality healthcare delivered everywhere,” says Kolko. “We are delighted to partner with forward-thinking Option Care to create new opportunities for patient-centered home infusion.”
About Shift Labs
Shift Labs, Inc. is a Seattle-based company that creates well-designed medical devices for fast-growing healthcare sectors, everywhere from alternate site care in the US to clinical care in emerging markets. The DripAssist Infusion Rate Monitor is their first product and has previously been recognized as one of Popular Science Magazine’s 12 Best Healthcare Innovations of 2016, as well as receiving the MedTech Conference’s 2017 Global Health Innovation Award, a Silver medal from the Industrial Designers Society of America IDEA awards and funding from USAID as part of the Ebola Grand Challenge and Saving Lives at Birth: A Grand Challenge for Development. Learn more at http://www.shiftlabs.com
About Option Care
Option Care Enterprises, Inc. (Option Care) is one of the nation’s largest and most trusted providers of home and alternate treatment site infusion services. An industry leader, the company draws on nearly 40 years of clinical care experience to offer patient-centered therapy management. Option Care’s signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support and care coordination. Option Care’s multidisciplinary team of more than 1,800 clinicians – including pharmacists, nurses and dietitians – are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions. Learn more at http://www.OptionCare.com.
Inquiries:
Contact CEO Beth Kolko, beth(at)shiftlabs.com, or CTO Koji Intlekofer, koji(at)shiftlabs.com at +1 206.369.1216.
Beth Kolko, CEO, Shift Labs, Inc., http://www.shiftlabs.com, +1 2063691216, [email protected]
Share this article